Merit Medical Systems (MMSI) Expected to Announce Earnings on Tuesday

Merit Medical Systems (NASDAQ:MMSI) will likely be posting its quarterly earnings results after the market closes on Tuesday, February 25th. Analysts expect Merit Medical Systems to post earnings of $0.82 per share and revenue of $351.54 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Merit Medical Systems Price Performance

Shares of NASDAQ MMSI opened at $103.16 on Monday. Merit Medical Systems has a fifty-two week low of $70.70 and a fifty-two week high of $111.45. The stock has a market cap of $6.01 billion, a price-to-earnings ratio of 50.57, a PEG ratio of 2.34 and a beta of 0.87. The company has a debt-to-equity ratio of 0.57, a quick ratio of 3.82 and a current ratio of 5.36. The firm’s 50-day simple moving average is $102.64 and its 200 day simple moving average is $99.64.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. Robert W. Baird raised their price target on shares of Merit Medical Systems from $107.00 to $109.00 and gave the company an “outperform” rating in a research report on Thursday, October 31st. Needham & Company LLC lifted their target price on shares of Merit Medical Systems from $109.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. Canaccord Genuity Group lifted their target price on shares of Merit Medical Systems from $127.00 to $128.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. Wells Fargo & Company raised shares of Merit Medical Systems from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $103.00 to $120.00 in a research report on Wednesday, December 11th. Finally, Piper Sandler reissued an “overweight” rating and set a $116.00 target price (up previously from $114.00) on shares of Merit Medical Systems in a research report on Wednesday, January 29th. Two research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Merit Medical Systems presently has a consensus rating of “Moderate Buy” and an average price target of $109.80.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.